Serious Game-based Interventions in Patients With Mild Cognitive Impairment Outside the Clinic

NCT04920123 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2025-08-07

Study results available
· View outcomes & findings →

Summary

This study will evaluate the therapeutic efficacy of Neuro-World cognitive training games (Woorisoft, S. Korea) in patients with mild cognitive impairment.

Conditions

Interventions

DEVICE

Neuro-World

Neuro-World is a collection of six games that are developed for cognitive training that focuses on memory and attention.

Sponsors & Collaborators

  • Rutgers, The State University of New Jersey

    collaborator OTHER
  • Université de Montréal

    collaborator OTHER
  • University of Massachusetts, Amherst

    lead OTHER

Principal Investigators

  • Sunghoon I Lee, PhD · University of Massachusetts, Amherst

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-17
Primary Completion
2025-03-31
Completion
2025-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04920123 on ClinicalTrials.gov